Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2018-10-11
Target enrollment:
Participant gender:
Summary
The study proposes to evaluate the safety and efficacy of the combination of trastuzumab
emtansine (T-DM1) and vinorelbine in HER2+ metastatic breast cancer patients.